相似文献/References:
[1]吉效东,张学新,曹金凤,等.中晚期食管癌的动脉灌注化疗及其风险浅评[J].介入放射学杂志,1996,(02):101.
[2]周祖德.胃癌术前介入治疗的疗效分析(附14例报告)[J].介入放射学杂志,1997,(01):45.
[3]程永德.动脉灌注化疗并栓塞治疗肝癌的若干问题[J].介入放射学杂志,1999,(04):186.
[4]王革芳,程永德,王咏梅,等.静脉滴注重组人血管内皮抑素联合动脉灌注化疗治疗晚期恶性肿瘤的临床观察[J].介入放射学杂志,2009,(04):270.
WANG Gefang,CHENG Yongde,WANG Yongmei,et al.Intravenous drip transfusion of recombinant human endostatin combined with arterial infusion chemotherapy for the treatment of advanced carcinomas:a clinical observation[J].journal interventional radiology,2009,(03):270.
[5]刘瑞宝,杨光,崔亚利,等.125I粒子植入联合动脉灌注化疗治疗不可切除性肺癌[J].介入放射学杂志,2009,(06):453.
LIU Rui-bao,YANG Guang,CUI Ya-li,et al.Evaluation of125I seed implantation combined with arterial infusion chemotherapy in treating unresectable lung cancer[J].journal interventional radiology,2009,(03):453.
[6]许立超,李文涛.乳腺癌介入治疗指南的建议[J].介入放射学杂志,2010,(06):425.
XU Lichao,LI Wentao.Suggestions about the guidelines for interventional therapy of breast cancer[J].journal interventional radiology,2010,(03):425.
[7]黄坤林,刘玉金.肺癌介入治疗临床研究进展[J].介入放射学杂志,2019,28(10):1005.
HUANG Kunlin,LIU Yujin..Recent progress in clinical application of interventional therapy for lung cancer[J].journal interventional radiology,2019,28(03):1005.
[8]章浙伟,曾 晖,郑家平,等.吉西他滨联合白蛋白结合型紫杉醇经导管动脉灌注治疗晚期胰腺癌的疗效及安全性[J].介入放射学杂志,2024,33(05):512.
ZHANG Zhewei,ZENG Hui,ZHENG Jiaping,et al.Efficacy and safety of transcatheter arterial infusion chemotherapy with gemcitabine and nab-paclitaxel regimen for advanced pancreatic cancer[J].journal interventional radiology,2024,33(03):512.